Regulation of the intestinal mucin MUC2 gene expression in vivo: Evidence for the role of promoter methylation

Cancer Letters

Volumn 168, Issue 1, 2001, Pages 71-80

  Gratchev, Alexei ^a   Siedow, Anja ^a   Bumke Vogt, Christiane ^a   Hummel, Michael ^b   Foss, Hans Dieter ^b   Hanski, Marie Luise ^a   Kobalz, Ursula ^a   Mann, Benno ^b   Lammert, Hedwig ^b   Stein, Harald ^b   Riecken, Ernst Otto ^a   Hanski, Christoph ^a   Mansmann, Ullrich ^b  

^a Medizinische Klinik I   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Colon carcinoma; Gene regulation; Methylation; Mucinous differentiation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MUCIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; COLORECTAL CARCINOMA; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE CONTROL; GENE EXPRESSION; GOBLET CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BLOTTING, NORTHERN; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GOBLET CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINES; MICE; MICE, NUDE; MODELS, GENETIC; MUCINS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS (GENETICS); RNA; TUMOR CELLS, CULTURED;

EID: 0035838585     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00498-0     Document Type: Article

References (24)

1. Chang S.K., Dohrmann A.F., Basbaum C.B., Ho S.B., Tsuda T., Toribara N.W., Gum J.R., Kim Y.S. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology. 107:1994;28-36.
2. Gambus G., de Bolos C., Andreu D., Franci C., Egea G., Real F.X. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenterology. 104:1993;93-102.
3. Weiss A.A., Babyatsky M.W., Ogata S., Chen A., Itzkowitz S.H. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J. Histochem. Cytochem. 44:1996;1161-1166.
4. Hanski C., Riede E., Gratchev A., Foss H.D., Bohm C., Klussmann E., Hummel M., Mann B., Buhr H.J., Stein H., Kim Y.S., Gum J., Riecken E.O. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab. Invest. 77:1997;685-695.
5. Feinberg A.P., Gehrke C.W., Kuo K.C., Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48:1988;1159-1161.
6. Silverman A.L., Park J.G., Hamilton S.R., Gazdar A.F., Luk G.D., Baylin S.B. Abnormal methylation of the calcitonin gene in human colonic neoplasms. Cancer Res. 49:1989;3468-3473.
7. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidransky D., Baylin S.B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:1995;4525-4530.
8. de Bustros A., Nelkin B.D., Silverman A., Ehrlich G., Poiesz B., Baylin S.B. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc. Natl. Acad. Sci. USA. 85:1988;5693-5697.
9. Gum J.R., Byrd J.C., Hicks J.W., Toribara N.W., Lamport D.T., Kim Y.S. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J. Biol. Chem. 264:1989;6480-6487.
10. x moiety is an independent and a more consistent marker of colon carcinogenesis than the overexpression of c-myc and Ki-ras oncogenes. Int. J. Oncol. 4:1994;993-1000.
11. Xing P.X., Prenzoska J., Layton G.T., Devine P.L., McKenzie I.F.C. Second generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J. Natl. Cancer Inst. 84:1992;699-703.
12. Yoo S., Ho I., Ogata S., Chen A., Maklansky J., Gendler S., Taylor-Papadimitriou J., Xing X.P., McKenzie I.F.C., Itzkowitz S.H. Unmasking of apomucin determinants in gastrointestinal tissues by a novel immunohistochemical technique. Gastroenterology. 104:1993;A410.
13. Blank M., Klussmann E., Krüger-Krasagakes S., Schmitt-Gräff A., Stolte M., Bornhoeft G., Stein H., Xing P.X., McKenzie I.F.C., Verstijnen C.P.H.J., Riecken E.O., Hanski C. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int. J. Cancer. 59:1994;301-306.
14. Olek A., Oswald J., Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res. 24:1996;5064-5066.
15. Gonzalgo M.L., Jones P.A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 25:1997;2529-2531.
16. Bohm M., Wieland I., Schutze K., Rubben H. Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue. Am. J. Pathol. 151:1997;63-67.
17. Elias J.M. Immunohistology. A Practical Approach to Diagnosis. 1990;ASCP Press, Chicago, IL.
18. Gum J.R., Hicks J.W., Kim Y.S. Identification and characterization of the MUC2 (human intestinal mucin) gene 5′-flanking region: promoter activity in cultured cells. Biochem. J. 325:1997;259-267.
19. Siegfried Z., Eden S., Mendelsohn M., Feng X., Tsuberi B.Z., Cedar H. DNA methylation represses transcription in vivo. Nat. Genet. 22:1999;203-206.
20. Serrano A., Garcia A., Abril E., Garrido F., Ruiz-Cabello F. Methylated CpG points identified within MAGE-1 promoter are involved in gene repression. Int. J. Cancer. 68:1996;464-470.
21. Goelz S.E., Vogelstein B., Hamilton S.R., Feinberg A.P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 228:1985;187-190.
22. Ahuja N., Mohan A.L., Li Q., Stolker J.M., Herman J.G., Hamilton S.R., Baylin S.B., Issa J.P. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57:1997;3370-3374.
23. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Danenberg P.V., Laird P.W. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59:1999;2302-2306.
24. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., Herman J.G. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res. 60:2000;129-133.